Evaluating the impact of the Optimal Care Pathway for neuroendocrine tumors on patient care in Australia
Diagnosed with a NET in 2021 or later? Share your insights!
If you’ve received a Neuroendocrine Tumour (NET) diagnosis in 2021 or beyond, we invite you to take part in an anonymous online survey. Your valuable input will aid us in unraveling the impact of the optimal care pathway for neuroendocrine tumours that was introduced in early 2023. Even if you’re unfamiliar with this pathway, your insights are highly valuable to us.
The main goal is to assess whether the optimal care pathway improves patient care and communication with healthcare professionals. Additionally, we aim to identify and address unmet patient needs.
The research findings will help us develop strategies to ensure that the intended benefits of the already-implemented optimal care pathway are realized, thus providing the best possible care to both current and future NET patients.
Your participation involves completing a confidential online survey, taking about 10-20 minutes. Participation is voluntary, and you can stop the survey at any time.
Please consider taking the time to contribute to this valuable research by completing the survey via the button below.
